A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

Mary Pollice, C KIM, Ryszard Dworski, J MURRAY, J.R. Sheller, James E. Fish, Stephen P. Peters

Journal of Allergy and Clinical Immunology · 1996 · 130 citations · 22 references

DOIFull text

Open access

Concepts

References

22